liu.seSearch for publications in DiVA
Operational message
There are currently operational disruptions. Troubleshooting is in progress.
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Time to Reevaluate the 95% Inclusion Criteria for Defining Reference Intervals?
Yale Sch Med, CT 06510 USA.
Royal Coll Pathologists Australasia, Australia.
Linköping University, Department of Biomedical and Clinical Sciences, Division of Clinical Chemistry and Pharmacology. Linköping University, Faculty of Medicine and Health Sciences.ORCID iD: 0000-0003-0756-7723
2024 (English)In: Clinical Chemistry, ISSN 0009-9147, E-ISSN 1530-8561, Vol. 70, no 5, p. 700-702Article in journal, Editorial material (Other academic) Published
Abstract [en]

When test results fall outside the reference intervals in healthy individuals, it often leads to frustration and unnecessary investigations for potential diseases. These anomalies can be attributed to matrix effects or lack of selectivity but more commonly are due to the strict criteria we use when designing reference intervals that ultimately could be narrow for some tests (1–3).

The central question we raise here is whether it is time to reevaluate and redesign our approach to creating reference intervals to reduce the occurrence of false positives while minimizing false negatives. Here we provide a condensed overview of the history, theory, and practical considerations regarding reference intervals and why we firmly believe we need to update our approach for some tests.

Place, publisher, year, edition, pages
OXFORD UNIV PRESS INC , 2024. Vol. 70, no 5, p. 700-702
National Category
Clinical Laboratory Medicine
Identifiers
URN: urn:nbn:se:liu:diva-201817DOI: 10.1093/clinchem/hvae026ISI: 001186530200001PubMedID: 38498011Scopus ID: 2-s2.0-85192112890OAI: oai:DiVA.org:liu-201817DiVA, id: diva2:1846691
Available from: 2024-03-25 Created: 2024-03-25 Last updated: 2025-08-15

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Theodorsson, Elvar
By organisation
Division of Clinical Chemistry and PharmacologyFaculty of Medicine and Health Sciences
In the same journal
Clinical Chemistry
Clinical Laboratory Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 143 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf